- Home
- VRCA vs FORA Comparison
VRCA vs FORA Comparison
Compare VRCA & FORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRCA
- FORA
- Stock Information
- Founded
- VRCA 2013
- FORA 2014
- Country
- VRCA United States
- FORA United States
- Employees
- VRCA N/A
- FORA N/A
- Industry
- VRCA Biotechnology: Pharmaceutical Preparations
- FORA Computer Software: Prepackaged Software
- Sector
- VRCA Health Care
- FORA Technology
- Exchange
- VRCA Nasdaq
- FORA Nasdaq
- Market Cap
- VRCA 58.0M
- FORA 62.7M
- IPO Year
- VRCA 2018
- FORA N/A
- Fundamental
- Price
- VRCA $0.49
- FORA $1.96
- Analyst Decision
- VRCA Hold
- FORA Strong Buy
- Analyst Count
- VRCA 5
- FORA 1
- Target Price
- VRCA $6.00
- FORA $5.00
- AVG Volume (30 Days)
- VRCA 614.0K
- FORA 30.3K
- Earning Date
- VRCA 05-12-2025
- FORA 05-13-2025
- Dividend Yield
- VRCA N/A
- FORA N/A
- EPS Growth
- VRCA N/A
- FORA N/A
- EPS
- VRCA N/A
- FORA N/A
- Revenue
- VRCA $7,566,000.00
- FORA $20,153,263.00
- Revenue This Year
- VRCA $127.58
- FORA $13.31
- Revenue Next Year
- VRCA $88.06
- FORA N/A
- P/E Ratio
- VRCA N/A
- FORA N/A
- Revenue Growth
- VRCA 47.66
- FORA N/A
- 52 Week Low
- VRCA $0.38
- FORA $1.85
- 52 Week High
- VRCA $11.41
- FORA $4.03
- Technical
- Relative Strength Index (RSI)
- VRCA 46.71
- FORA 46.06
- Support Level
- VRCA $0.38
- FORA $1.90
- Resistance Level
- VRCA $0.59
- FORA $2.08
- Average True Range (ATR)
- VRCA 0.09
- FORA 0.12
- MACD
- VRCA 0.01
- FORA 0.02
- Stochastic Oscillator
- VRCA 40.52
- FORA 41.02
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.
About FORA Forian Inc.
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.